Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
UK Peptides Check Order Status My Account Login / Register Login Register Wishlist Edit your wishlist 0 Blog Research Hub Back Account Login Register FAQ Demos About us Contact We Ship the Same Day When You Order Before 3PM
Dose-Response Relationships In animal stroke models, gene expression changes occurred 1-24 hours post-administration, but whether similar timing applies to psychiatric effects is unknown
The neurological research path is even earlier stage
This program is not suitable for individuals with a history of medullary thyroid carcinoma (MTC) , multiple endocrine neoplasia syndrome type 2 (MEN 2), or anyone with severe allergic reactions to the medications
Key Features D-retro-inverso peptide model for in vitro research Suitable for studies involving FOXO-associated proteinprotein interactions Used in controlled investigations of senescence-related cellular pathways Supplied as a lyophilised powder for convenient handling and storage 10 mg per vial Released only after internal quality control review Specifications for FOXO4-DRI Product name: FOXO4-DRI Also known as: FOXO4 DRI, FOXO4 peptide (D-retro-inverso), FOX04, FOX04-DRI Class: Peptide analogue (research use) Form: Lyophilised powder Unit size: 10 mg Appearance: White to off-white solid Lot note: Counter-ion content and hydration state may vary between batches
Our Commitment Apexion products are formulated, filled, and packaged under controlled conditions to support stability & consistency
